These findings suggest that while anti-TNF-α therapy does not directly increase the risk of acquiring LTBI, its association with positive QFT-Plus results in this study likely reflects confounding factors, such as TB exposure, rather than a direct effect on latent infection. Here, TNF is linked to disease arising from reactivation of latent virus.